The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
